Eric Tang
Papers
2
Total Citations
80
H-Index
2
About
Eric Tang has been instrumental in advancing the precision and reliability of compound dosing in drug discovery, particularly through the validation and implementation of acoustic droplet ejection (ADE) technology. His key research areas include assay miniaturization, cell-based screening, and liquid handling automation. Tang’s most impactful work, "Achieving Accurate Compound Concentration in Cell-Based Screening: Validation of Acoustic Droplet Ejection Technology" (2009, 58 citations), established ADE as a gold standard for direct compound dosing, dramatically improving accuracy and reducing reagent waste in high-throughput screening. He further detailed the practical challenges and solutions of scaling this technology in his 2015 paper (22 citations), which documented AstraZeneca’s global adoption of the Labcyte Echo system since 2005. Tang’s contributions have enabled more reliable cell-based assays, accelerating hit-to-lead timelines across the pharmaceutical industry. His work is widely cited by researchers seeking robust, reproducible methods for compound management, and his validation studies remain foundational for labs transitioning to acoustic dispensing. Tang’s achievements exemplify how engineering precision can transform biological screening.
Research Focus
Key Achievements
Top Papers
- 1
- 2